Regulatory Exclusivity: PATENT CHALLENGE
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Drugs with Patent Challenge Regulatory Exclusivity
Click here to include patents covering these drugs in this list
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Exclusivity Expiration | Patented / Exclusive Use |
---|---|---|---|---|---|---|---|---|---|---|---|
Bionpharma Inc | ENALAPRIL MALEATE | enalapril maleate | SOLUTION;ORAL | 212408-001 | Aug 10, 2021 | AB | RX | No | No | ⤷ Try a Trial | PATENT CHALLENGE |
Taro | ADAPALENE AND BENZOYL PEROXIDE | adapalene; benzoyl peroxide | GEL;TOPICAL | 209148-001 | Oct 17, 2018 | AB | RX | No | No | ⤷ Try a Trial | PATENT CHALLENGE |
Teva Pharms Usa | NALOXONE HYDROCHLORIDE | naloxone hydrochloride | SPRAY, METERED;NASAL | 209522-001 | Apr 19, 2019 | AB | RX | No | No | ⤷ Try a Trial | PATENT CHALLENGE |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Exclusivity Expiration | >Patented / Exclusive Use |